WUHAN, China, Dec. 1, 2020 /PRNewswire/ — Dunxin Financial Holdings Limited (“Dunxin” or the “Company” NYSE American: DXF), a licensed microfinance lender serving individuals and small and medium enterprises (SMEs) in Hubei Province, China, today announced that the Company signed an Intentional Cooperation Agreement with Baite Biological Group Co., Ltd. The Company and Baite Biological Group plan to carry out cooperation in market expansion and production research and development in three aspects: (1) In Vitro Diagnostic industry, (2) hospital intelligent laboratory, (3) production and manufacturing of high-end medical devices.
Baite Biological Group Co., Ltd. is a research, production, trade in one of the digital laboratory medical analysis instruments and in vitro diagnostic reagent enterprises, is a national high-tech enterprises in the People’s Republic of China.
Safe Harbor Statement
This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “target,” “going forward,” “outlook” and similar statements. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
About Dunxin Financial Holdings Limited
Dunxin Financial Holdings Limited (“DXF”) is one of the leading licensed microfinance lenders in Hubei Province, China. We have been granted a microfinance license by the Financial Affairs Office of the Hubei Provincial People’s Government to provide loans to individuals, small and medium-sized enterprises. We were awarded as the Vice President Unit of China Micro-credit Companies Association under the China Banking Regulatory Commission in January 2017 and the President Unit of Hubei Micro-credit Company Association in December 2017. In 2016, we were recognized as a “National Excellent Microfinance Company” by China Micro-credit Companies Association. We have been named one of the “Top 100 Most Competitive Microfinance Companies in China” by China Microfinance Institution Association for four consecutive years since 2013, an “AA- Credit Rating Enterprise” by China Credit Management Co., Ltd in August 2017, and a “Top 10 Private Enterprises in Wuchang District, Wuhan City” by the People’s Government of Wuchang District in July 2017. The Group has a strong capital base and professional credit business experience in microfinance industry.
For additional information, please contact: +86-1365 5939 932.
View original content:https://www.prnewswire.com/news-releases/dunxin-financial-holdings-limited-announced-the-signing-of-intentional-cooperation-agreement-with-baite-biological-group-co-ltd-301181523.html
